We’re delighted to announce that Kathy Levy, GO2 for Lung Cancer’s ALCASE Project Manager, was a finalist for the prestigious C2 Catalyst for Equity award. The award recognizes people who have worked to overcome longstanding racial and ethnic disparities in cancer care, ensuring that all people have equitable access to quality care.

Headshot of Kathy Levy

Kathy Levy, Manager, ALCASE Project

Levy was nominated for her work on improving access to lung cancer screening. As the manager of GO2 for Lung Cancer’s Alabama Lung Cancer Awareness, Screening, and Education (ALCASE) project, she collaborates with the University of Alabama, Birmingham, to target seven, mostly rural, African-American counties.

The project has three main goals:

  • Deploying nearly 190 county coordinators and volunteer community health advisors to educate family, neighbors and other community members about lung cancer risk and screening.
  • To increase access to quality lung cancer screening.
  • To identify ways to assist those at high risk for lung cancer through the screening process.

ALCASE is the first widespread use of community health advisors to educate and navigate high-risk individuals to lung cancer screening and to increase access to quality screening.

“Every single day we are out in our communities talking to people and helping them to get screened for lung cancer,” said Levy.

For Levy, nomination recognizes her passion to make a difference. Born and raised in Butler, AL, Levy is known in her community as “the cancer lady.” She has spent more than 30 years addressing cancer disparities in African-American and underserved communities.

The C2 Awards, presented by AstraZeneca, honors people who have been recognized by their peers for the inspiring work they do each day—all collectively working to make a difference for those living with and affected by cancer.